Skip to main content
. 2018 Jun;7(3):327–335. doi: 10.21037/tlcr.2018.05.13

Figure 1.

Figure 1

Pro-SFTPB and DAS as risk markers. (A) Receiver operator characteristic of a smoking based risk model applied to the Pan Canadian Lung Screening cohort and significantly improved performance of the combined base model together with pro-SFTPB; (B) additive performance of Diacetyl spermine, together with pro-SFTPB in a blinded validation study using pre-diagnostic samples from a high risk cohort.